Paul Rothman Laboratory Corp Of America Holdings (LH) insider trading activity

LH Quotes by TradingView

Paul Rothman is Director of LABORATORY CORP OF AMERICA HOLDINGS. Currently has a direct ownership of 1,674 shares of LH, which is worth approximately $418,248. The most recent transaction as insider was on Feb 06, 2025, when has been sold 944 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.67K
133.47% 3M change
n/a 12M change
Total Value Held $418,248

Paul Rothman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2025
BUY
Exercise of conversion of derivative security
-
944 Added 36.06%
1,674 Common Stock
Jun 06 2024
BUY
Exercise of conversion of derivative security
-
717 Added 50.0%
717 Common Stock

Also insider at

VYNT
Vyant Bio, Inc. Healthcare
Director
MRK
Merck & Co., Inc. Healthcare
Director
PR

Paul Rothman

Director
Rutherford, NJ

Track Institutional and Insider Activities on LH

Follow LABORATORY CORP OF AMERICA HOLDINGS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LH shares.

Notify only if

Insider Trading

Get notified when an Laboratory Corp Of America Holdings insider buys or sells LH shares.

Notify only if

News

Receive news related to LABORATORY CORP OF AMERICA HOLDINGS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LH